Effectiveness and safety of azathioprine for inflammatory pouch disorders: results from the RESERVO study of GETECCU

Background: The usefulness of thiopurines has been poorly explored in pouchitis and other pouch disorders.Objective: To evaluate the effectiveness and safety of azathioprine as maintenance therapy in inflammatory pouch disorders.Design: This was a retrospective and multicentre study.Methods: We incl...

Descripción completa

Detalles Bibliográficos
Autores: Mesonero, F, Zabana, Y, Fernández-Clotet, A, Leo-Carnerero, E, Caballol, B, Núñez-Ortiz, A, García, MJ, Bertoletti, F, Mínguez, A, Suris, G, Casis, B, Ferreiro-Iglesias, R, Calafat, M, Jiménez, I, Miranda-Bautista, J, Lamuela, LJ, Fajardo, I, Torrealba, L, Nájera, R, Saíz-Chumillas, RM, González, I, Vicuña, M, García-Morales, N, Gutiérrez, A, López-García, A, Benítez, JM, de Célix, CR, Tejido, C, Brunet, E, Hernández-Camba, A, Suárez, C, Rodríguez-Lago, I, Piqueras, M, Castaño, A, Ramos, L, Sobrino, A, Rodríguez-Grau, MC, Elosua, A, Montoro, M, Baltar, R, Huguet, JM, Hermida, B, Caballero-Mateos, A, Sánchez-Guillén, L, Bouhmidi, A, Pajares, R, Baston-Rey, I, López-Sanromán, A, Albillos, A, Barreiro-de Acosta, M
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2024
País:España
Institución:Instituto de Investigación Biomédica y Sanitaria de Alicante (ISABIAL)
Repositorio:r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
OAI Identifier:oai:isabial.fundanetsuite.com:p10135
Acceso en línea:https://isabial.portalinvestigacion.com/publicaciones10135
https://journals.sagepub.com/doi/10.1177/17562848241234476
Access Level:acceso abierto
Palabra clave:azathioprine
immunosuppressants
pouchitis
thiopurines
id ES_64a1485d0cf2eeb1e8ff91e949e44cbe
oai_identifier_str oai:isabial.fundanetsuite.com:p10135
network_acronym_str ES
network_name_str España
repository_id_str
spelling Effectiveness and safety of azathioprine for inflammatory pouch disorders: results from the RESERVO study of GETECCUMesonero, FZabana, YFernández-Clotet, ALeo-Carnerero, ECaballol, BNúñez-Ortiz, AGarcía, MJBertoletti, FMínguez, ASuris, GCasis, BFerreiro-Iglesias, RCalafat, MJiménez, IMiranda-Bautista, JLamuela, LJFajardo, ITorrealba, LNájera, RSaíz-Chumillas, RMGonzález, IVicuña, MGarcía-Morales, NGutiérrez, ALópez-García, ABenítez, JMde Célix, CRTejido, CBrunet, EHernández-Camba, ASuárez, CRodríguez-Lago, IPiqueras, MCastaño, ARamos, LSobrino, ARodríguez-Grau, MCElosua, AMontoro, MBaltar, RHuguet, JMHermida, BCaballero-Mateos, ASánchez-Guillén, LBouhmidi, APajares, RBaston-Rey, ILópez-Sanromán, AAlbillos, ABarreiro-de Acosta, MazathioprineimmunosuppressantspouchitisthiopurinesBackground: The usefulness of thiopurines has been poorly explored in pouchitis and other pouch disorders.Objective: To evaluate the effectiveness and safety of azathioprine as maintenance therapy in inflammatory pouch disorders.Design: This was a retrospective and multicentre study.Methods: We included patients diagnosed with inflammatory pouch disorders treated with azathioprine in monotherapy. Effectiveness was evaluated at 1 year and in the long term based on normalization of stool frequency, absence of pain, faecal urgency or fistula discharge (clinical remission), or any improvement in these symptoms (clinical response). Endoscopic response was evaluated using the Pouchitis Disease Activity Index (PDAI).Results: In all, 63 patients were included [54% males; median age, 49 (28-77) years]. The therapy was used to treat pouchitis (n = 37) or Crohn's disease of the pouch (n = 26). The rate of clinical response, remission and non-response at 12 months were 52%, 30% and 18%, respectively. After a median follow-up of 23 months (interquartile range 11-55), 19 patients (30%) were in clinical remission, and 45 (66%) stopped therapy. Endoscopic changes were evaluated in 19 cases. PDAI score decreased from 3 (range 2-4) to 1 (range 0-3). In all, 21 patients (33%) presented adverse events and 16 (25%) needed to stop therapy.Conclusion: Azathioprine may be effective in the long term for the treatment of inflammatory pouch disorders and could be included as a therapeutic option.SAGE PUBLICATIONS LTD2024info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttps://isabial.portalinvestigacion.com/publicaciones10135https://journals.sagepub.com/doi/10.1177/17562848241234476Therapeutic Advances in GastroenterologyISSN: 1756283XISSNe: 17562848reponame:r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicanteinstname:Instituto de Investigación Biomédica y Sanitaria de Alicante (ISABIAL)Inglésinfo:eu-repo/semantics/openAccessoai:isabial.fundanetsuite.com:p101352026-06-12T10:20:37Z
dc.title.none.fl_str_mv Effectiveness and safety of azathioprine for inflammatory pouch disorders: results from the RESERVO study of GETECCU
title Effectiveness and safety of azathioprine for inflammatory pouch disorders: results from the RESERVO study of GETECCU
spellingShingle Effectiveness and safety of azathioprine for inflammatory pouch disorders: results from the RESERVO study of GETECCU
Mesonero, F
azathioprine
immunosuppressants
pouchitis
thiopurines
title_short Effectiveness and safety of azathioprine for inflammatory pouch disorders: results from the RESERVO study of GETECCU
title_full Effectiveness and safety of azathioprine for inflammatory pouch disorders: results from the RESERVO study of GETECCU
title_fullStr Effectiveness and safety of azathioprine for inflammatory pouch disorders: results from the RESERVO study of GETECCU
title_full_unstemmed Effectiveness and safety of azathioprine for inflammatory pouch disorders: results from the RESERVO study of GETECCU
title_sort Effectiveness and safety of azathioprine for inflammatory pouch disorders: results from the RESERVO study of GETECCU
dc.creator.none.fl_str_mv Mesonero, F
Zabana, Y
Fernández-Clotet, A
Leo-Carnerero, E
Caballol, B
Núñez-Ortiz, A
García, MJ
Bertoletti, F
Mínguez, A
Suris, G
Casis, B
Ferreiro-Iglesias, R
Calafat, M
Jiménez, I
Miranda-Bautista, J
Lamuela, LJ
Fajardo, I
Torrealba, L
Nájera, R
Saíz-Chumillas, RM
González, I
Vicuña, M
García-Morales, N
Gutiérrez, A
López-García, A
Benítez, JM
de Célix, CR
Tejido, C
Brunet, E
Hernández-Camba, A
Suárez, C
Rodríguez-Lago, I
Piqueras, M
Castaño, A
Ramos, L
Sobrino, A
Rodríguez-Grau, MC
Elosua, A
Montoro, M
Baltar, R
Huguet, JM
Hermida, B
Caballero-Mateos, A
Sánchez-Guillén, L
Bouhmidi, A
Pajares, R
Baston-Rey, I
López-Sanromán, A
Albillos, A
Barreiro-de Acosta, M
author Mesonero, F
author_facet Mesonero, F
Zabana, Y
Fernández-Clotet, A
Leo-Carnerero, E
Caballol, B
Núñez-Ortiz, A
García, MJ
Bertoletti, F
Mínguez, A
Suris, G
Casis, B
Ferreiro-Iglesias, R
Calafat, M
Jiménez, I
Miranda-Bautista, J
Lamuela, LJ
Fajardo, I
Torrealba, L
Nájera, R
Saíz-Chumillas, RM
González, I
Vicuña, M
García-Morales, N
Gutiérrez, A
López-García, A
Benítez, JM
de Célix, CR
Tejido, C
Brunet, E
Hernández-Camba, A
Suárez, C
Rodríguez-Lago, I
Piqueras, M
Castaño, A
Ramos, L
Sobrino, A
Rodríguez-Grau, MC
Elosua, A
Montoro, M
Baltar, R
Huguet, JM
Hermida, B
Caballero-Mateos, A
Sánchez-Guillén, L
Bouhmidi, A
Pajares, R
Baston-Rey, I
López-Sanromán, A
Albillos, A
Barreiro-de Acosta, M
author_role author
author2 Zabana, Y
Fernández-Clotet, A
Leo-Carnerero, E
Caballol, B
Núñez-Ortiz, A
García, MJ
Bertoletti, F
Mínguez, A
Suris, G
Casis, B
Ferreiro-Iglesias, R
Calafat, M
Jiménez, I
Miranda-Bautista, J
Lamuela, LJ
Fajardo, I
Torrealba, L
Nájera, R
Saíz-Chumillas, RM
González, I
Vicuña, M
García-Morales, N
Gutiérrez, A
López-García, A
Benítez, JM
de Célix, CR
Tejido, C
Brunet, E
Hernández-Camba, A
Suárez, C
Rodríguez-Lago, I
Piqueras, M
Castaño, A
Ramos, L
Sobrino, A
Rodríguez-Grau, MC
Elosua, A
Montoro, M
Baltar, R
Huguet, JM
Hermida, B
Caballero-Mateos, A
Sánchez-Guillén, L
Bouhmidi, A
Pajares, R
Baston-Rey, I
López-Sanromán, A
Albillos, A
Barreiro-de Acosta, M
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv azathioprine
immunosuppressants
pouchitis
thiopurines
topic azathioprine
immunosuppressants
pouchitis
thiopurines
description Background: The usefulness of thiopurines has been poorly explored in pouchitis and other pouch disorders.Objective: To evaluate the effectiveness and safety of azathioprine as maintenance therapy in inflammatory pouch disorders.Design: This was a retrospective and multicentre study.Methods: We included patients diagnosed with inflammatory pouch disorders treated with azathioprine in monotherapy. Effectiveness was evaluated at 1 year and in the long term based on normalization of stool frequency, absence of pain, faecal urgency or fistula discharge (clinical remission), or any improvement in these symptoms (clinical response). Endoscopic response was evaluated using the Pouchitis Disease Activity Index (PDAI).Results: In all, 63 patients were included [54% males; median age, 49 (28-77) years]. The therapy was used to treat pouchitis (n = 37) or Crohn's disease of the pouch (n = 26). The rate of clinical response, remission and non-response at 12 months were 52%, 30% and 18%, respectively. After a median follow-up of 23 months (interquartile range 11-55), 19 patients (30%) were in clinical remission, and 45 (66%) stopped therapy. Endoscopic changes were evaluated in 19 cases. PDAI score decreased from 3 (range 2-4) to 1 (range 0-3). In all, 21 patients (33%) presented adverse events and 16 (25%) needed to stop therapy.Conclusion: Azathioprine may be effective in the long term for the treatment of inflammatory pouch disorders and could be included as a therapeutic option.
publishDate 2024
dc.date.none.fl_str_mv 2024
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://isabial.portalinvestigacion.com/publicaciones10135
https://journals.sagepub.com/doi/10.1177/17562848241234476
url https://isabial.portalinvestigacion.com/publicaciones10135
https://journals.sagepub.com/doi/10.1177/17562848241234476
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv SAGE PUBLICATIONS LTD
publisher.none.fl_str_mv SAGE PUBLICATIONS LTD
dc.source.none.fl_str_mv Therapeutic Advances in Gastroenterology
ISSN: 1756283X
ISSNe: 17562848
reponame:r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname:Instituto de Investigación Biomédica y Sanitaria de Alicante (ISABIAL)
instname_str Instituto de Investigación Biomédica y Sanitaria de Alicante (ISABIAL)
reponame_str r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
collection r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869409670720913408
score 15.81155